Literature DB >> 31708658

Implementing a one-day testing model improves timeliness of workup for patients with lung cancer.

M A Gulak1,2, C Bornais2, S Shin2, L Murphy2, J Smylie2, J R Pantarotto1,2,3, M Fung-Kee-Fung1,2,4, D E Maziak1,2,5.   

Abstract

Background: Patients with lung cancer often experience stressful delays throughout the diagnostic phase of care. To address that situation, our multidisciplinary team created a "Navigation Day," during which patients partake in a single-day visit that comprises nurse-led teaching, social work, smoking cessation counselling, symptom control, and dedicated test slots for integrated positron-emission tomography and computed tomography (pet/ct), pulmonary function tests (pfts), and magnetic resonance imaging (mri) of the brain. We evaluated the effects of that program on wait times and patient satisfaction.
Methods: Patients with a suspicion of lung cancer on chest ct imaging referred during 3 time periods were reviewed: 1 year before launch of the Navigation Day, 1 year post-launch, and 2 years post-launch. Patients were further stratified according to concordance of their test date with a Navigation Day date. Mean wait times for pet/ct, pfts, and mri brain were calculated for each group. Patient satisfaction was measured using a standardized provincial survey. The Student t-test and analysis of variance were used to assess for significance.
Results: After implementation, mean wait times in the first year improved to 9.2 days from 15.5 days for pet/ct (p < 0.0001), to 9.6 days from 15.7 days for pfts (p < 0.0001), and to 10.2 days from 16.0 days for mri brain (p < 0.0001). Patients who used a dedicated test slot experienced the shortest wait times, at 5.8 days for pet/ct, 5.8 days for pfts, and 6.3 days for mri brain (p < 0.0001). Those improvements were sustained at 2 years post-launch. Patient satisfaction in the categories of assistance, emotional support, and clarity remained high post-launch. Conclusions: Navigation Day significantly improved the timeliness of diagnostic testing services in patients with suspected lung cancer. 2019 Multimed Inc.

Entities:  

Keywords:  Lung cancer; clinical pathways; diagnostic assessment programs; diagnostic delay; diagnostic testing; nurse navigators; wait times

Year:  2019        PMID: 31708658      PMCID: PMC6821128          DOI: 10.3747/co.26.4927

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  11 in total

1.  Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis.

Authors:  Dorothy S Lo; Robert A Zeldin; Roland Skrastins; Ian M Fraser; Harold Newman; Alan Monavvari; Yee C Ung; Harry Joseph; Teresa Downton; Larissa Maxwell; Jacinta Meharchand
Journal:  J Thorac Oncol       Date:  2007-11       Impact factor: 15.609

2.  Reducing Wait Time for Lung Cancer Diagnosis and Treatment: Impact of a Multidisciplinary, Centralized Referral Program.

Authors:  Jessica L Common; Hensley H Mariathas; Kaylah Parsons; Jonathan D Greenland; Scott Harris; Rick Bhatia; Suzanne C Byrne
Journal:  Can Assoc Radiol J       Date:  2018-06-04       Impact factor: 2.248

Review 3.  Timeliness of care in patients with lung cancer: a systematic review.

Authors:  J K Olsson; E M Schultz; M K Gould
Journal:  Thorax       Date:  2009-09       Impact factor: 9.139

4.  The effect of a lung cancer care coordination program on timeliness of care.

Authors:  Susan Alsamarai; Xiaopan Yao; Hilary C Cain; Bryan W Chang; Herta H Chao; Donna M Connery; Yanhong Deng; Vijay N Garla; Laura S Hunnibell; Anthony W Kim; J Antonio Obando; Caroline Taylor; George Tellides; Michal G Rose
Journal:  Clin Lung Cancer       Date:  2013-07-01       Impact factor: 4.785

5.  Diagnostic accuracy of MRI compared to CCT in patients with brain metastases.

Authors:  P D Schellinger; H M Meinck; A Thron
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

6.  Distress in suspected lung cancer patients following rapid and standard diagnostic programs: a prospective observational study.

Authors:  Pepijn Brocken; Erik H F M van der Heijden; Karen T M Oud; Gerben Bootsma; Harry J M Groen; A Rogier T Donders; P N Richard Dekhuijzen; Judith B Prins
Journal:  Psychooncology       Date:  2014-09-09       Impact factor: 3.894

Review 7.  Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review.

Authors:  Margo M Jacobsen; Sophie C Silverstein; Michael Quinn; Leo B Waterston; Christian A Thomas; James C Benneyan; Paul K J Han
Journal:  Lung Cancer       Date:  2017-08-15       Impact factor: 5.705

8.  The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer.

Authors:  N Subedi; A Scarsbrook; M Darby; K Korde; P Mc Shane; M F Muers
Journal:  Lung Cancer       Date:  2008-11-11       Impact factor: 5.705

9.  Regional process redesign of lung cancer care: a learning health system pilot project.

Authors:  M Fung-Kee-Fung; D E Maziak; J R Pantarotto; J Smylie; L Taylor; T Timlin; T Cacciotti; P J Villeneuve; C Dennie; C Bornais; S Madore; J Aquino; P Wheatley-Price; R S Ozer; D J Stewart
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

10.  Health-related quality of life, anxiety and depression in the diagnostic phase of suspected cancer, and the influence of diagnosis.

Authors:  Ellen Moseholm; Susan Rydahl-Hansen; Dorthe Overgaard; Hanne S Wengel; Rikke Frederiksen; Malene Brandt; Bjarne Ø Lindhardt
Journal:  Health Qual Life Outcomes       Date:  2016-05-20       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.